Shortness of Breath on Exertion

What is Exertional Dyspnea?

Exertional dyspnea — commonly known as shortness of breath on exertion
(ICD-10: R06.0) — is the subjective sensation of breathing difficulty or air hunger that appears
or worsens during physical activity. It is one of the most frequent complaints in primary care
and cardiology offices, estimated to affect up to 25% of adults in varying degrees.

A certain degree of increased breathing during exertion is completely normal: the body increases
ventilation to deliver more oxygen to working muscles. The problem arises when dyspnea is
disproportionate to the level of effort, limits daily activities, or develops at
intensities that previously caused no symptoms.

The causes of exertional dyspnea range from relatively benign (deconditioning, mild anemia)
to immediately life-threatening (acute coronary syndrome, pulmonary embolism, severe aortic
stenosis). This is why any new or worsening exertional dyspnea requires medical evaluation —
in particular, an ECG and echocardiogram to rule out serious cardiac pathology.

NYHA Functional Classification of Exertional Dyspnea

In cardiology, the NYHA (New York Heart Association) classification is widely used
to assess the severity of exertional dyspnea and the degree of physical limitation. Developed
by the American Heart Association, it divides patients into four functional classes.

Table 1. NYHA (New York Heart Association) functional classification of exertional dyspnea.
Survival figures apply primarily to patients with chronic heart failure.
Source: AHA/ACC Heart Failure Guidelines 2022.

Cardiac Causes of Exertional Dyspnea

Heart disease is one of the most serious and most common causes of exertional dyspnea.
The underlying mechanism is usually the same: the heart is unable to pump enough oxygenated
blood to the working muscles, leading to rapid accumulation of lactic acid and stimulation
of respiratory receptors.

Chronic Heart Failure (HF)

Chronic heart failure is the most common cardiac cause of exertional dyspnea in adults over 65. It is estimated that
over 64 million people worldwide live with HF. Both HFrEF (reduced ejection fraction EF <40%)
and HFpEF (preserved EF ≥50%) impair ventricular filling or emptying, raising pulmonary venous
pressure and producing dyspnea. Characteristic features include orthopnea (dyspnea worsening
when lying flat) and paroxysmal nocturnal dyspnea (PND). Exertional dyspnea is typically
graded using the NYHA classification described above.

Coronary Artery Disease (CAD) and Myocardial Infarction

Myocardial ischemia during exertion may manifest not only as typical angina (chest pain)
but also as a so-called anginal equivalent — exertional dyspnea without accompanying
chest pain. This occurs particularly in women, people with diabetes, and elderly patients.
In acute coronary syndrome (ACS / heart attack), sudden dyspnea accompanied by diaphoresis
and grey skin color requires immediate emergency care. Read more about chest pain types and when to seek help.

Valvular Heart Disease

Aortic stenosis (AS) is the most common acquired valvular disease in adults in developed countries.
The classic triad includes exertional dyspnea, angina, and exertional syncope. Severe aortic
stenosis presenting with dyspnea is an indication for urgent valve replacement (TAVI or surgical).
Mitral regurgitation (MR) causes volume overload of the left ventricle; gradually progressive
exertional dyspnea is its hallmark symptom. Suspected valvular disease should always be evaluated
with an echocardiogram — see our overview of cardiac diagnostic tests.

Cardiomyopathies

Hypertrophic cardiomyopathy (HCM) is a genetic disorder characterized by left ventricular
hypertrophy without an obvious hemodynamic cause. It presents with exertional dyspnea, chest pain,
and syncope, and is a leading cause of sudden cardiac death in young athletes. Dilated
cardiomyopathy (DCM) impairs systolic function, producing progressive exertional dyspnea
corresponding to NYHA class II–IV. Both conditions may show characteristic findings on
ECG.

Cardiac Arrhythmias

Atrial fibrillation (AF) — the most common sustained arrhythmia in adults — impairs ventricular filling and reduces cardiac
output, causing marked exercise intolerance. Paroxysmal ventricular tachycardia (VT) or supraventricular tachycardia (SVT)
triggered by exercise can cause sudden, severe dyspnea. In some patients, bradycardia or atrioventricular blocks limit heart rate reserve during exertion, producing significant dyspnea at low workloads.
A cardiac stress test is particularly valuable in unmasking exercise-induced arrhythmias.

Pulmonary Hypertension

Pulmonary arterial hypertension (PAH) is a rare but severe disease characterized by progressive
exertional dyspnea, fatigue, and syncope. Diagnosis is often delayed by several years from the
onset of first symptoms. NYHA class III–IV carries poor prognosis without specific therapy
(prostacyclins, endothelin receptor antagonists, PDE-5 inhibitors). Ventricular remodeling
caused by sustained pressure overload is discussed in our article on ventricular remodeling.

Pulmonary Causes of Exertional Dyspnea

Respiratory diseases are the second most frequent group of causes of exertional dyspnea.
Mechanisms include: increased work of breathing (airway obstruction, reduced lung compliance),
impaired gas exchange, and exercise-induced hypoxemia.

Chronic Obstructive Pulmonary Disease (COPD)

COPD is one of the most common chronic diseases worldwide and the leading pulmonary cause
of exertional dyspnea in current and former smokers. The mechanism involves bronchial
obstruction, air trapping, and diaphragm flattening. The characteristic pattern is dyspnea
that worsens gradually over years, often dismissed by patients as “normal aging.”
Diagnosis is confirmed by spirometry (post-bronchodilator FEV1/FVC <0.70).
Treatment is based on inhaled LABA, LAMA, and inhaled corticosteroids (ICS).

Asthma (Exercise-Induced Bronchoconstriction, EIB)

Asthma may present as exertional dyspnea (exercise-induced bronchoconstriction) without
typical resting attacks. Bronchoconstriction typically occurs 5–15 minutes after
stopping exercise, rather than during it. The hallmark is symptom variability and a good
response to short-acting beta-2 agonists (SABA). If you are scheduled for cardiac testing,
it is important to inform your doctor of asthma medications — see our article on who should avoid a cardiac stress test.

Pulmonary Embolism (PE)

Acute pulmonary embolism is a life-threatening condition in which sudden dyspnea —
especially following immobilization, surgery, or a long flight — is the leading symptom.
Associated features include pleuritic chest pain, tachycardia, oxygen desaturation (SpO₂ drop),
and occasionally hemoptysis. Chronic thromboembolic pulmonary hypertension (CTEPH) presents
with subacutely progressive exertional dyspnea and is a rare but under-recognized cause.

Interstitial Lung Diseases (ILD)

Idiopathic pulmonary fibrosis (IPF), sarcoidosis, and other ILDs reduce diffusing capacity
(DLCO) and cause gradually worsening exertional dyspnea. Characteristic features include
bibasilar crackles on auscultation, digital clubbing, and reduced forced vital capacity
(FVC <80% predicted) on spirometry. High-resolution CT (HRCT) of the chest is the
investigation of choice.

Pleural and Chest Wall Disorders

Pneumothorax, pleural effusion (transudative or exudative), severe kyphoscoliosis, and
obesity hypoventilation syndrome (Pickwickian syndrome) mechanically restrict chest wall
and diaphragm movement, producing dyspnea that is particularly evident during exertion.

Other Causes of Exertional Dyspnea

Anemia

Anemia — regardless of etiology (iron deficiency, vitamin B12, folate deficiency; hemolysis;
malignancy-related) — reduces the oxygen-carrying capacity of blood. The body compensates
by increasing respiratory rate and depth, which the patient perceives as exertional dyspnea.
Characteristic findings include pallor of skin, mucosae, and conjunctivae, tachycardia,
fatigue, and tinnitus. A complete blood count with differential and ferritin level are
the key screening tests.

Obesity and Deconditioning

Obesity (BMI ≥30 kg/m²) is a frequently underestimated cause of exertional dyspnea.
Excess body weight increases cardiac and respiratory workload, restricts diaphragm movement,
and promotes low-grade systemic inflammation that raises small airway resistance.
Sedentary individuals with poor aerobic fitness (VO₂max <20 mL/kg/min) report dyspnea
even at low workloads. Gradual, supervised exercise rehabilitation is the cornerstone
of management.

Anxiety Disorders and Hyperventilation Syndrome

Panic disorder and hyperventilation syndrome can mimic exertional dyspnea. Characteristic
features include paresthesias of the hands and perioral region, a sensation of choking,
dizziness, and paradoxically very high SpO₂ (often above 99%). A functional diagnosis
is made only after organic causes have been excluded. A non-stigmatizing approach and
cognitive-behavioral therapy are central to management.

Thyroid Disorders and Other Endocrine Conditions

Hypothyroidism reduces cardiac output and may cause pericardial effusion, edema, and
exertional dyspnea. Hyperthyroidism increases metabolic demands and may trigger
atrial fibrillation with exercise intolerance. Diabetes with autonomic neuropathy disrupts heart rate
regulation during exercise.

Neuromuscular Diseases

Amyotrophic lateral sclerosis (ALS), myasthenia gravis, myopathies, and high spinal cord
injuries weaken respiratory muscles, causing restrictive exertional dyspnea. The hallmark
sign is paradoxical abdominal movement (abdominal wall drawing inward during inspiration),
indicating diaphragm paralysis.

Differential Diagnosis – Urgency Table

The table below presents the most important causes of exertional dyspnea categorized by
urgency of management: red — life-threatening, requiring immediate emergency care;
orange — urgent consultation within 24–48 hours; green — planned outpatient workup.

How is Exertional Dyspnea Diagnosed?

The diagnostic approach should be targeted: the history and physical examination drive
the choice of investigations. There is no single algorithm that fits every patient.

Medical History

Key questions include: duration and dynamics of symptoms (sudden vs. gradual), triggers
(type of exertion, temperature, stress), associated symptoms (chest pain, palpitations,
leg swelling, cough, hemoptysis), cardiovascular and pulmonary history, current medications
(beta-blockers, ACE inhibitors, beta-agonists), smoking history, and occupational exposure
to dust or fumes.

Physical Examination

Cardiac auscultation (valvular murmurs, extra heart sounds S3/S4), pulmonary auscultation
(wheezes, rhonchi, crackles, reduced breath sounds), pulse regularity and rate, blood pressure,
SpO₂ saturation, jugular venous pressure (JVP), peripheral edema, digital clubbing,
central and peripheral cyanosis.

First-line Investigations

Essential first-line tests include: a 12-lead ECG (arrhythmias, evidence of prior myocardial infarction, left ventricular hypertrophy),
complete blood count with differential (anemia, leukocytosis), chest X-ray (cardiomegaly,
pulmonary congestion, parenchymal changes), echocardiogram (systolic and diastolic function,
valvular disease, pulmonary artery pressure), and spirometry (obstructive vs. restrictive pattern).
For a full overview of available cardiac investigations, see our guide to cardiac diagnostic tests.

Second-line Investigations

Depending on first-line results: BNP/NT-proBNP (heart failure marker),
cardiac stress test (exercise ECG or cardiopulmonary exercise test, CPET)
— the gold standard for diagnosing dyspnea of unclear origin (see our detailed article on what to expect during a stress test and who should avoid it),
Holter ECG monitoring (exercise-induced arrhythmias),
HRCT chest (interstitial lung disease),
CT pulmonary angiography (pulmonary embolism),
D-dimer, ferritin, serum iron (iron deficiency anemia),
TSH (thyroid disease), and right heart catheterization (confirmation of pulmonary hypertension).
If coronary artery disease is suspected, a coronary angiogram may be indicated.

Treatment and Management

Treatment of exertional dyspnea is entirely dependent on the underlying cause.
Below are the main therapeutic strategies for the most common etiologies.

Cardiac Treatment

In heart failure with reduced ejection fraction (HFrEF), guideline-directed medical therapy (GDMT) includes:
ACE inhibitors/ARBs/ARNI (sacubitril/valsartan), beta-blockers
(bisoprolol, carvedilol), mineralocorticoid receptor antagonists (eplerenone),
and SGLT2 inhibitors (dapagliflozin, empagliflozin — proven to reduce
hospitalizations and mortality). For valvular disease, percutaneous interventions (TAVI,
MitraClip) or cardiac surgery are indicated. In atrial fibrillation,
rate or rhythm control and thromboembolic prophylaxis (NOAC/VKA) are priorities.
Patients who experience cardiogenic shock represent the most severe end of this spectrum and require intensive care.

Pulmonary Treatment

In COPD, long-acting inhaled bronchodilators (LABA, LAMA) are the foundation of treatment,
combined with pulmonary rehabilitation. In exercise-induced asthma, pre-medication with SABA
15–20 minutes before exercise, or chronic treatment with inhaled corticosteroids (ICS),
is effective. In IPF, nintedanib or pirfenidone slow fibrosis progression; in pulmonary
hypertension, prostacyclins, endothelin receptor antagonists, and PDE-5 inhibitors
are used.

Treatment of Anemia

Iron deficiency anemia requires oral or intravenous iron supplementation and elimination
of the bleeding source. In severe anemia (Hb <7 g/dL with symptoms), red blood cell
transfusion may be necessary. Megaloblastic anemia requires vitamin B12 or folate
supplementation.

Cardiac Rehabilitation and Exercise Training

Regardless of etiology, cardiopulmonary rehabilitation is a key component
of managing exertional dyspnea. Regular aerobic exercise improves peripheral muscle efficiency
and reduces the subjective sensation of dyspnea at a given workload (peripheral adaptation
effect). Exercise should be supervised and tailored to the patient’s NYHA class.
Before starting rehabilitation, many patients will need a cardiac stress test to guide safe exercise prescription.

Non-pharmacological Management

Includes: smoking cessation (critical in COPD), weight reduction in obesity, sodium and
fluid restriction in heart failure, avoidance of bronchoconstriction triggers, thromboprophylaxis,
and vaccinations (influenza, pneumococcal in COPD and HF). Preventive cardiology measures
for high-risk patients are discussed in our preventive cardiology section.